CCG
RMD icon

Cypress Capital Group’s ResMed RMD Stock Holding History

Cypress Capital Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-927
Closed -$226K – 297
2024
Q3 		$226K Buy
+927
New +$207K 0.03% 287
2022
Q1 		– Sell
-983
Closed -$256K – 333
2021
Q4 		$256K Buy
983
+115
+13% +$29.8K 0.03% 274
2021
Q3 		$229K Hold
868
– – 0.03% 258
2021
Q2 		$214K Buy
+868
New +$182K 0.03% 268
2021
Q1 		– Sell
-950
Closed -$202K – 291
2020
Q4 		$202K Buy
+950
New +$189K 0.03% 261
2020
Q3 		– Sell
-1,089
Closed -$209K – 265
2020
Q2 		$209K Buy
+1,089
New +$178K 0.04% 234

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cypress Capital Group's RMD Position: Q4 2024 in Review

Cypress Capital Group sold out of ResMed (RMD) in Q4 2024, closing a stake of 927 shares — an estimated $226K sold.

Cypress Capital Group first reported a position in RMD in Q2 2020 and held it in 6 quarters. The position peaked at $256K in Q4 2021. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Cypress Capital Group reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Cypress Capital Group sold 927 ResMed shares in Q4 2024, an estimated $226K.
  • Cypress Capital Group first reported a position in ResMed in Q2 2020 and held it in 6 quarters.
  • Cypress Capital Group's ResMed position peaked at $256K in Q4 2021.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Cypress Capital Group's 13F filing for Q4 2024, filed 6 Feb 2025.